Abstract

Schizoaffective disorder (SA) is distinguished from schizophrenia (SZ) based on the presence of prominent mood symptoms over the illness course. Despite this clinical distinction, SA and SZ patients are often combined in research studies, in part because data supporting a distinct pathophysiological boundary between the disorders are lacking. Indeed, few studies have addressed whether neurobiological abnormalities associated with SZ, such as the widely replicated reduction and delay of the P300 event-related potential (ERP), are also present in SA. Scalp EEG was acquired from patients with DSM-IV SA (n = 15) or SZ (n = 22), as well as healthy controls (HC; n = 22) to assess the P300 elicited by infrequent target (15%) and task-irrelevant distractor (15%) stimuli in separate auditory and visual ”oddball” tasks. P300 amplitude was reduced and delayed in SZ, relative to HC, consistent with prior studies. These SZ abnormalities did not interact with stimulus type (target vs. task-irrelevant distractor) or modality (auditory vs. visual). Across sensory modality and stimulus type, SA patients exhibited normal P300 amplitudes (significantly larger than SZ patients and indistinguishable from HC). However, P300 latency and reaction time were both equivalently delayed in SZ and SA patients, relative to HC. P300 differences between SA and SZ patients could not be accounted for by variation in symptom severity, socio-economic status, education, or illness duration. Although both groups show similar deficits in processing speed, SA patients do not exhibit the P300 amplitude deficits evident in SZ, consistent with an underlying pathophysiological boundary between these disorders.

Highlights

  • Kraepelin (1971) distinguished between “dementia praecox” and “manic-depressive psychosis” based on his observations that these two groups of psychotic patients exhibited different clusters of symptoms and courses of illness

  • All but one patient were on stable doses of antipsychotic medications and met DSM-IV (American Psychiatric Association, 1994) criteria for schizophrenia or schizoaffective disorder based on a Structured Clinical Interview for DSM-IV (SCID) (First et al, 1995)

  • A significant Deviant Type × Group interaction was parsed with sub-analysis of variance (ANOVA) within each group; the Deviant Type effect on accuracy was greater in the SZ and Schizoaffective disorder (SA) groups than in the healthy controls (HC) group

Read more

Summary

Introduction

Kraepelin (1971) distinguished between “dementia praecox” and “manic-depressive psychosis” based on his observations that these two groups of psychotic patients exhibited different clusters of symptoms and courses of illness. This distinction has persisted in psychiatric nosology, underlying the current diagnostic categories of schizophrenia and major mood disorders. Perhaps because definitive data supporting a pathophysiological boundary between the disorders are lacking, schizoaffective and schizophrenia patients are often combined in schizophrenia research

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.